Table 2.
Cancer site | Men | Women | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | |||||||||
RR | 95 % | CI | RR | 95 % | CI | RR | 95 % | CI | RR | 95 % | CI | |
Buccal cavity and pharynx | ||||||||||||
Approach A q2a | 0.996 | 0.926–1.071 | 1.050 | 0.977–1.128 | 1.014 | 0.898–1.144 | 1.061 | 0.944–1.190 | ||||
q3 | 0.973 | 0.901–1.050 | 1.053 | 0.981–1.131 | 0.994 | 0.879–1.124 | 1.044 | 0.931–1.170 | ||||
q4 | 0.947 | 0.875–1.026 | 1.025 | 0.958–1.096 | 1.105 | 0.979–1.242 | 1.149 | 1.036–1.274 | ||||
Trend testb | 0.981 | 0.956–1.007 | 1.006 | 0.984–1.027 | 1.033 | 0.993–1.072 | 1.044 | 1.010–1.078 | ||||
Approach B SPDEc | 0.970 | 0.900–1.037 | 0.938 | 0.835–1.024 | 1.096 | 0.967–1.233 | 1.118 | 1.003–1.250 | ||||
Oesophagus | ||||||||||||
Approach A q2a | 0.949 | 0.883–1.020 | 0.932 | 0.867–1.002 | 0.945 | 0.798–1.120 | 0.942 | 0.796–1.115 | ||||
q3 | 0.883 | 0.818–0.953 | 0.889 | 0.827–0.955 | 0.993 | 0.838–1.177 | 1.021 | 0.867–1.203 | ||||
q4 | 0.947 | 0.875–1.025 | 0.954 | 0.891–1.021 | 1.220 | 1.038–1.435 | 1.328 | 1.146–1.544 | ||||
Trend testb | 0.981 | 0.955–1.006 | 0.985 | 0.964–1.007 | 1.078 | 1.022–1.137 | 1.115 | 1.063–1.170 | ||||
Approach B PDE c | 0.978 | 0.893–1.060 | 0.990 | 0.901–1.129 | 1.254 | 0.989–1.497 | 1.263 | 0.991–1.508 | ||||
Liver | ||||||||||||
Approach A q2a | 1.104 | 1.011–1.206 | 1.003 | 0.926–1.086 | 0.973 | 0.853–1.110 | 0.864 | 0.761–0.980 | ||||
q3 | 1.027 | 0.934–1.130 | 0.944 | 0.871–1.022 | 1.020 | 0.889–1.172 | 0.921 | 0.814–1.041 | ||||
q4 | 1.097 | 0.992–1.213 | 0.982 | 0.911–1.059 | 1.041 | 0.902–1.201 | 0.935 | 0.833–1.049 | ||||
Trend testb | 1.021 | 0.989–1.055 | 0.990 | 0.967–1.014 | 1.017 | 0.971–1.066 | 0.989 | 0.953–1.026 | ||||
Approach B SPDEc | 1.026 | 0.930–1.151 | 1.051 | 0.948–1.197 | 1.050 | 0.905–1.198 | 1.020 | 0.891–1.184 | ||||
Larynx | ||||||||||||
Approach A q2a | 0.930 | 0.864–1.001 | 0.944 | 0.879–1.013 | 1.122 | 0.871–1.444 | 1.188 | 0.909–1.550 | ||||
q3 | 0.965 | 0.893–1.042 | 1.009 | 0.941–1.082 | 1.116 | 0.866–1.435 | 1.206 | 0.925–1.571 | ||||
q4 | 0.930 | 0.858–1.008 | 1.012 | 0.947–1.081 | 1.175 | 0.954–1.453 | 1.188 | 0.940–1.507 | ||||
Trend testb | 0.982 | 0.957–1.008 | 1.011 | 0.990–1.032 | 1.049 | 0.982–1.121 | 1.048 | 0.974–1.127 | ||||
Approach B SPDEc | 0.963 | 0.827–1.068 | 0.990 | 0.905–1.074 | 1.279 | 1.040–1.567 | 1.295 | 1.037–1.611 | ||||
Pleura | ||||||||||||
Approach A q2a | 1.052 | 0.840–1.318 | 0.970 | 0.777–1.209 | 0.951 | 0.701–1.291 | 0.879 | 0.666–1.157 | ||||
q3 | 1.192 | 0.944–1.508 | 1.223 | 0.990–1.51 | 1.162 | 0.866–1.554 | 1.312 | 1.020–1.686 | ||||
q4 | 1.099 | 0.856–1.408 | 1.046 | 0.854–1.282 | 1.273 | 0.961–1.690 | 1.239 | 0.989–1.557 | ||||
Trend testb | 1.037 | 0.957–1.123 | 1.030 | 0.967–1.098 | 1.098 | 1.002–1.203 | 1.103 | 1.027–1.185 | ||||
Approach B SPDEc | 1.182 | 0.891–1.515 | 1.201 | 0.915–1.746 | 1.474 | 1.120–1.975 | 1.399 | 1.074–1.871 | ||||
Breast | ||||||||||||
Approach A q2a | 1.028 | 0.986–1.072 | 1.042 | 1.003–1.081 | ||||||||
q3 | 0.992 | 0.949–1.036 | 1.015 | 0.977–1.053 | ||||||||
q4 | 1.007 | 0.961–1.054 | 1.045 | 1.009–1.082 | ||||||||
Trend testb | 0.998 | 0.984–1.013 | 1.011 | 1.000–1.022 | ||||||||
Approach B SPDEc | 0.972 | 0.927–1.022 | 0.976 | 0.934–1.020 | ||||||||
Uterus | ||||||||||||
Approach A q2a | 0.989 | 0.930–1.051 | 1.022 | 0.963–1.086 | ||||||||
q3 | 0.991 | 0.930–1.055 | 1.031 | 0.971–1.094 | ||||||||
q4 | 1.046 | 0.982–1.113 | 1.089 | 1.031–1.151 | ||||||||
Trend testb | 1.016 | 0.996–1.037 | 1.029 | 1.011–1.047 | ||||||||
Approach B SPDEc | 1.079 | 1.019–1.130 | 1.026 | 0.963–1.092 | ||||||||
Kidney | ||||||||||||
Approach A q2a | 1.061 | 0.984–1.145 | 1.063 | 0.993–1.139 | 0.952 | 0.863–1.049 | 0.931 | 0.853–1.015 | ||||
q3 | 1.056 | 0.976–1.142 | 1.093 | 1.021–1.170 | 0.964 | 0.872–1.065 | 0.990 | 0.908–1.077 | ||||
q4 | 1.026 | 0.945–1.113 | 1.034 | 0.969–1.103 | 1.005 | 0.911–1.108 | 0.990 | 0.917–1.070 | ||||
Trend testb | 1.005 | 0.979–1.031 | 1.008 | 0.988–1.029 | 1.005 | 0.974–1.038 | 1.004 | 0.980–1.030 | ||||
Approach B SPDEc | 1.009 | 0.926–1.095 | 1.005 | 0.929–1.083 | 0.981 | 0.887–1.081 | 0.980 | 0.880–1.077 | ||||
NHL | ||||||||||||
Approach A q2a | 1.022 | 0.944–1.106 | 1.013 | 0.939–1.092 | 1.049 | 0.972–1.132 | 1.050 | 0.974–1.131 | ||||
q3 | 1.032 | 0.952–1.119 | 1.061 | 0.986–1.142 | 1.029 | 0.953–1.112 | 1.058 | 0.982–1.139 | ||||
q4 | 0.994 | 0.915–1.080 | 0.987 | 0.919–1.059 | 1.076 | 0.997–1.161 | 1.092 | 1.018–1.170 | ||||
Trend testb | 0.997 | 0.971–1.024 | 0.997 | 0.975–1.02 | 1.021 | 0.996–1.046 | 1.027 | 1.005–1.050 | ||||
Approach B SPDEc | 0.994 | 0.915–1.080 | 0.984 | 0.909–1.067 | 1.062 | 0.985–1.132 | 1.064 | 0.988–1.143 |
The table shows the results of the approaches A and B, broken down as follows: unadjusted (model n.1) and adjusted for socio-demographic variables and industrial emissions (model n.3)
aQuartiles: reference [6.46, 20.2], q2 [20.24, 25.0], q3 [24.99, 29.9] and q4 [29.86, 243.7 mg kg−1]
bRR, taking quartiles as a categorical variable
cRR for a change of one unit in the logarithm of the elements’ soil concentration